nodes	percent_of_prediction	percent_of_DWPC	metapath
Penciclovir—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.0016	0.0016	CcSEcCtD
Penciclovir—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.0016	0.0016	CcSEcCtD
Penciclovir—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.00159	0.00159	CcSEcCtD
Penciclovir—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.00157	0.00157	CcSEcCtD
Penciclovir—Neutropenia—Ramipril—type 2 diabetes mellitus	0.00157	0.00157	CcSEcCtD
Penciclovir—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00156	0.00156	CcSEcCtD
Penciclovir—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00156	0.00156	CcSEcCtD
Penciclovir—Hypoaesthesia—Losartan—type 2 diabetes mellitus	0.00156	0.00156	CcSEcCtD
Penciclovir—Nausea—Repaglinide—type 2 diabetes mellitus	0.00156	0.00156	CcSEcCtD
Penciclovir—Asthenia—Glipizide—type 2 diabetes mellitus	0.00156	0.00156	CcSEcCtD
Penciclovir—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.00155	0.00155	CcSEcCtD
Penciclovir—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00155	0.00155	CcSEcCtD
Penciclovir—Cardiac disorder—Irbesartan—type 2 diabetes mellitus	0.00155	0.00155	CcSEcCtD
Penciclovir—Angioedema—Valsartan—type 2 diabetes mellitus	0.00154	0.00154	CcSEcCtD
Penciclovir—Erythema—Metformin—type 2 diabetes mellitus	0.00154	0.00154	CcSEcCtD
Penciclovir—Pruritus—Glipizide—type 2 diabetes mellitus	0.00153	0.00153	CcSEcCtD
Penciclovir—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.00153	0.00153	CcSEcCtD
Penciclovir—Angioedema—Orlistat—type 2 diabetes mellitus	0.00152	0.00152	CcSEcCtD
Penciclovir—Flatulence—Metformin—type 2 diabetes mellitus	0.00151	0.00151	CcSEcCtD
Penciclovir—Confusional state—Gliclazide—type 2 diabetes mellitus	0.00151	0.00151	CcSEcCtD
Penciclovir—Dysgeusia—Metformin—type 2 diabetes mellitus	0.0015	0.0015	CcSEcCtD
Penciclovir—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.0015	0.0015	CcSEcCtD
Penciclovir—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.0015	0.0015	CcSEcCtD
Penciclovir—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.00149	0.00149	CcSEcCtD
Penciclovir—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.00149	0.00149	CcSEcCtD
Penciclovir—Palpitations—Valsartan—type 2 diabetes mellitus	0.00149	0.00149	CcSEcCtD
Penciclovir—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.00149	0.00149	CcSEcCtD
Penciclovir—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.00149	0.00149	CcSEcCtD
Penciclovir—Stevens-Johnson syndrome—Ramipril—type 2 diabetes mellitus	0.00148	0.00148	CcSEcCtD
Penciclovir—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.00148	0.00148	CcSEcCtD
Penciclovir—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.00148	0.00148	CcSEcCtD
Penciclovir—Palpitations—Orlistat—type 2 diabetes mellitus	0.00147	0.00147	CcSEcCtD
Penciclovir—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00147	0.00147	CcSEcCtD
Penciclovir—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.00147	0.00147	CcSEcCtD
Penciclovir—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.00147	0.00147	CcSEcCtD
Penciclovir—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.00146	0.00146	CcSEcCtD
Penciclovir—Asthenia—Glimepiride—type 2 diabetes mellitus	0.00145	0.00145	CcSEcCtD
Penciclovir—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.00145	0.00145	CcSEcCtD
Penciclovir—Erythema—Irbesartan—type 2 diabetes mellitus	0.00145	0.00145	CcSEcCtD
Penciclovir—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.00145	0.00145	CcSEcCtD
Penciclovir—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.00144	0.00144	CcSEcCtD
Penciclovir—Dizziness—Glipizide—type 2 diabetes mellitus	0.00143	0.00143	CcSEcCtD
Penciclovir—Pruritus—Glimepiride—type 2 diabetes mellitus	0.00143	0.00143	CcSEcCtD
Penciclovir—Flatulence—Irbesartan—type 2 diabetes mellitus	0.00143	0.00143	CcSEcCtD
Penciclovir—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.00143	0.00143	CcSEcCtD
Penciclovir—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.00142	0.00142	CcSEcCtD
Penciclovir—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.00142	0.00142	CcSEcCtD
Penciclovir—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.00142	0.00142	CcSEcCtD
Penciclovir—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.00141	0.00141	CcSEcCtD
Penciclovir—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.00138	0.00138	CcSEcCtD
Penciclovir—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.00138	0.00138	CcSEcCtD
Penciclovir—Vomiting—Glipizide—type 2 diabetes mellitus	0.00138	0.00138	CcSEcCtD
Penciclovir—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.00138	0.00138	CcSEcCtD
Penciclovir—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00137	0.00137	CcSEcCtD
Penciclovir—Rash—Glipizide—type 2 diabetes mellitus	0.00137	0.00137	CcSEcCtD
Penciclovir—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00137	0.00137	CcSEcCtD
Penciclovir—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.00136	0.00136	CcSEcCtD
Penciclovir—Erythema—Losartan—type 2 diabetes mellitus	0.00136	0.00136	CcSEcCtD
Penciclovir—Headache—Glipizide—type 2 diabetes mellitus	0.00136	0.00136	CcSEcCtD
Penciclovir—Palpitations—Metformin—type 2 diabetes mellitus	0.00136	0.00136	CcSEcCtD
Penciclovir—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.00135	0.00135	CcSEcCtD
Penciclovir—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.00135	0.00135	CcSEcCtD
Penciclovir—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.00135	0.00135	CcSEcCtD
Penciclovir—Flatulence—Losartan—type 2 diabetes mellitus	0.00134	0.00134	CcSEcCtD
Penciclovir—Anaemia—Irbesartan—type 2 diabetes mellitus	0.00134	0.00134	CcSEcCtD
Penciclovir—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00134	0.00134	CcSEcCtD
Penciclovir—Skin disorder—Valsartan—type 2 diabetes mellitus	0.00134	0.00134	CcSEcCtD
Penciclovir—Dysgeusia—Losartan—type 2 diabetes mellitus	0.00134	0.00134	CcSEcCtD
Penciclovir—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.00133	0.00133	CcSEcCtD
Penciclovir—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00133	0.00133	CcSEcCtD
Penciclovir—Somnolence—Gliclazide—type 2 diabetes mellitus	0.00133	0.00133	CcSEcCtD
Penciclovir—Urticaria—Glyburide—type 2 diabetes mellitus	0.00133	0.00133	CcSEcCtD
Penciclovir—Angioedema—Irbesartan—type 2 diabetes mellitus	0.00132	0.00132	CcSEcCtD
Penciclovir—Skin disorder—Orlistat—type 2 diabetes mellitus	0.00132	0.00132	CcSEcCtD
Penciclovir—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.00132	0.00132	CcSEcCtD
Penciclovir—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.00131	0.00131	CcSEcCtD
Penciclovir—Headache—Pioglitazone—type 2 diabetes mellitus	0.0013	0.0013	CcSEcCtD
Penciclovir—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.0013	0.0013	CcSEcCtD
Penciclovir—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.0013	0.0013	CcSEcCtD
Penciclovir—Fatigue—Gliclazide—type 2 diabetes mellitus	0.00129	0.00129	CcSEcCtD
Penciclovir—Nausea—Glipizide—type 2 diabetes mellitus	0.00129	0.00129	CcSEcCtD
Penciclovir—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00129	0.00129	CcSEcCtD
Penciclovir—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00128	0.00128	CcSEcCtD
Penciclovir—Pain—Gliclazide—type 2 diabetes mellitus	0.00128	0.00128	CcSEcCtD
Penciclovir—Rash—Glimepiride—type 2 diabetes mellitus	0.00128	0.00128	CcSEcCtD
Penciclovir—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00127	0.00127	CcSEcCtD
Penciclovir—Rash—Sitagliptin—type 2 diabetes mellitus	0.00127	0.00127	CcSEcCtD
Penciclovir—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00127	0.00127	CcSEcCtD
Penciclovir—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.00127	0.00127	CcSEcCtD
Penciclovir—Headache—Glimepiride—type 2 diabetes mellitus	0.00127	0.00127	CcSEcCtD
Penciclovir—Headache—Sitagliptin—type 2 diabetes mellitus	0.00126	0.00126	CcSEcCtD
Penciclovir—Anaemia—Losartan—type 2 diabetes mellitus	0.00126	0.00126	CcSEcCtD
Penciclovir—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.00125	0.00125	CcSEcCtD
Penciclovir—Angioedema—Losartan—type 2 diabetes mellitus	0.00125	0.00125	CcSEcCtD
Penciclovir—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.00124	0.00124	CcSEcCtD
Penciclovir—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.00123	0.00123	CcSEcCtD
Penciclovir—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.00123	0.00123	CcSEcCtD
Penciclovir—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.00123	0.00123	CcSEcCtD
Penciclovir—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.00123	0.00123	CcSEcCtD
Penciclovir—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.00123	0.00123	CcSEcCtD
Penciclovir—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.00123	0.00123	CcSEcCtD
Penciclovir—Somnolence—Valsartan—type 2 diabetes mellitus	0.00122	0.00122	CcSEcCtD
Penciclovir—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.00122	0.00122	CcSEcCtD
Penciclovir—Leukopenia—Losartan—type 2 diabetes mellitus	0.00122	0.00122	CcSEcCtD
Penciclovir—Skin disorder—Metformin—type 2 diabetes mellitus	0.00122	0.00122	CcSEcCtD
Penciclovir—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00121	0.00121	CcSEcCtD
Penciclovir—Palpitations—Losartan—type 2 diabetes mellitus	0.00121	0.00121	CcSEcCtD
Penciclovir—Nausea—Glimepiride—type 2 diabetes mellitus	0.0012	0.0012	CcSEcCtD
Penciclovir—Nausea—Sitagliptin—type 2 diabetes mellitus	0.0012	0.0012	CcSEcCtD
Penciclovir—Asthenia—Glyburide—type 2 diabetes mellitus	0.0012	0.0012	CcSEcCtD
Penciclovir—Urticaria—Gliclazide—type 2 diabetes mellitus	0.00119	0.00119	CcSEcCtD
Penciclovir—Fatigue—Valsartan—type 2 diabetes mellitus	0.00119	0.00119	CcSEcCtD
Penciclovir—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.00118	0.00118	CcSEcCtD
Penciclovir—Pruritus—Glyburide—type 2 diabetes mellitus	0.00118	0.00118	CcSEcCtD
Penciclovir—Mental disorder—Ramipril—type 2 diabetes mellitus	0.00118	0.00118	CcSEcCtD
Penciclovir—Fatigue—Orlistat—type 2 diabetes mellitus	0.00117	0.00117	CcSEcCtD
Penciclovir—Erythema—Ramipril—type 2 diabetes mellitus	0.00117	0.00117	CcSEcCtD
Penciclovir—Pain—Orlistat—type 2 diabetes mellitus	0.00116	0.00116	CcSEcCtD
Penciclovir—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00116	0.00116	CcSEcCtD
Penciclovir—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.00116	0.00116	CcSEcCtD
Penciclovir—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.00116	0.00116	CcSEcCtD
Penciclovir—Rash—Bromocriptine—type 2 diabetes mellitus	0.00115	0.00115	CcSEcCtD
Penciclovir—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00115	0.00115	CcSEcCtD
Penciclovir—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.00115	0.00115	CcSEcCtD
Penciclovir—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.00115	0.00115	CcSEcCtD
Penciclovir—Headache—Bromocriptine—type 2 diabetes mellitus	0.00114	0.00114	CcSEcCtD
Penciclovir—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.00114	0.00114	CcSEcCtD
Penciclovir—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.00113	0.00113	CcSEcCtD
Penciclovir—Paraesthesia—Metformin—type 2 diabetes mellitus	0.00113	0.00113	CcSEcCtD
Penciclovir—Confusional state—Losartan—type 2 diabetes mellitus	0.00112	0.00112	CcSEcCtD
Penciclovir—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.00112	0.00112	CcSEcCtD
Penciclovir—Somnolence—Metformin—type 2 diabetes mellitus	0.00111	0.00111	CcSEcCtD
Penciclovir—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.00111	0.00111	CcSEcCtD
Penciclovir—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.0011	0.0011	CcSEcCtD
Penciclovir—Urticaria—Valsartan—type 2 diabetes mellitus	0.00109	0.00109	CcSEcCtD
Penciclovir—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.00109	0.00109	CcSEcCtD
Penciclovir—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.00109	0.00109	CcSEcCtD
Penciclovir—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.00109	0.00109	CcSEcCtD
Penciclovir—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00108	0.00108	CcSEcCtD
Penciclovir—Fatigue—Metformin—type 2 diabetes mellitus	0.00108	0.00108	CcSEcCtD
Penciclovir—Urticaria—Orlistat—type 2 diabetes mellitus	0.00108	0.00108	CcSEcCtD
Penciclovir—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.00108	0.00108	CcSEcCtD
Penciclovir—Asthenia—Gliclazide—type 2 diabetes mellitus	0.00108	0.00108	CcSEcCtD
Penciclovir—Angioedema—Ramipril—type 2 diabetes mellitus	0.00107	0.00107	CcSEcCtD
Penciclovir—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.00106	0.00106	CcSEcCtD
Penciclovir—Vomiting—Glyburide—type 2 diabetes mellitus	0.00106	0.00106	CcSEcCtD
Penciclovir—Pruritus—Gliclazide—type 2 diabetes mellitus	0.00106	0.00106	CcSEcCtD
Penciclovir—Rash—Glyburide—type 2 diabetes mellitus	0.00105	0.00105	CcSEcCtD
Penciclovir—Somnolence—Irbesartan—type 2 diabetes mellitus	0.00105	0.00105	CcSEcCtD
Penciclovir—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00105	0.00105	CcSEcCtD
Penciclovir—Leukopenia—Ramipril—type 2 diabetes mellitus	0.00105	0.00105	CcSEcCtD
Penciclovir—Headache—Glyburide—type 2 diabetes mellitus	0.00105	0.00105	CcSEcCtD
Penciclovir—Palpitations—Ramipril—type 2 diabetes mellitus	0.00103	0.00103	CcSEcCtD
Penciclovir—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.00103	0.00103	CcSEcCtD
Penciclovir—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.00103	0.00103	CcSEcCtD
Penciclovir—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.00103	0.00103	CcSEcCtD
Penciclovir—Fatigue—Irbesartan—type 2 diabetes mellitus	0.00102	0.00102	CcSEcCtD
Penciclovir—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.00101	0.00101	CcSEcCtD
Penciclovir—Pain—Irbesartan—type 2 diabetes mellitus	0.00101	0.00101	CcSEcCtD
Penciclovir—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.001	0.001	CcSEcCtD
Penciclovir—Paraesthesia—Losartan—type 2 diabetes mellitus	0.001	0.001	CcSEcCtD
Penciclovir—Urticaria—Metformin—type 2 diabetes mellitus	0.000996	0.000996	CcSEcCtD
Penciclovir—Nausea—Glyburide—type 2 diabetes mellitus	0.000991	0.000991	CcSEcCtD
Penciclovir—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000991	0.000991	CcSEcCtD
Penciclovir—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000991	0.000991	CcSEcCtD
Penciclovir—Somnolence—Losartan—type 2 diabetes mellitus	0.00099	0.00099	CcSEcCtD
Penciclovir—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000989	0.000989	CcSEcCtD
Penciclovir—Asthenia—Valsartan—type 2 diabetes mellitus	0.000988	0.000988	CcSEcCtD
Penciclovir—Asthenia—Orlistat—type 2 diabetes mellitus	0.000976	0.000976	CcSEcCtD
Penciclovir—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000975	0.000975	CcSEcCtD
Penciclovir—Pruritus—Valsartan—type 2 diabetes mellitus	0.000974	0.000974	CcSEcCtD
Penciclovir—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000967	0.000967	CcSEcCtD
Penciclovir—Confusional state—Ramipril—type 2 diabetes mellitus	0.000963	0.000963	CcSEcCtD
Penciclovir—Pruritus—Orlistat—type 2 diabetes mellitus	0.000962	0.000962	CcSEcCtD
Penciclovir—Fatigue—Losartan—type 2 diabetes mellitus	0.00096	0.00096	CcSEcCtD
Penciclovir—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000953	0.000953	CcSEcCtD
Penciclovir—Pain—Losartan—type 2 diabetes mellitus	0.000952	0.000952	CcSEcCtD
Penciclovir—Rash—Gliclazide—type 2 diabetes mellitus	0.000945	0.000945	CcSEcCtD
Penciclovir—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000944	0.000944	CcSEcCtD
Penciclovir—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000942	0.000942	CcSEcCtD
Penciclovir—Urticaria—Irbesartan—type 2 diabetes mellitus	0.00094	0.00094	CcSEcCtD
Penciclovir—Headache—Gliclazide—type 2 diabetes mellitus	0.000939	0.000939	CcSEcCtD
Penciclovir—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000936	0.000936	CcSEcCtD
Penciclovir—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000935	0.000935	CcSEcCtD
Penciclovir—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000935	0.000935	CcSEcCtD
Penciclovir—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000931	0.000931	CcSEcCtD
Penciclovir—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000927	0.000927	CcSEcCtD
Penciclovir—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000918	0.000918	CcSEcCtD
Penciclovir—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.00091	0.00091	CcSEcCtD
Penciclovir—Dizziness—Valsartan—type 2 diabetes mellitus	0.00091	0.00091	CcSEcCtD
Penciclovir—Dizziness—Orlistat—type 2 diabetes mellitus	0.0009	0.0009	CcSEcCtD
Penciclovir—Asthenia—Metformin—type 2 diabetes mellitus	0.000899	0.000899	CcSEcCtD
Penciclovir—Nausea—Gliclazide—type 2 diabetes mellitus	0.00089	0.00089	CcSEcCtD
Penciclovir—Pruritus—Metformin—type 2 diabetes mellitus	0.000887	0.000887	CcSEcCtD
Penciclovir—Urticaria—Losartan—type 2 diabetes mellitus	0.000885	0.000885	CcSEcCtD
Penciclovir—Abdominal pain—Losartan—type 2 diabetes mellitus	0.00088	0.00088	CcSEcCtD
Penciclovir—Vomiting—Valsartan—type 2 diabetes mellitus	0.000875	0.000875	CcSEcCtD
Penciclovir—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000872	0.000872	CcSEcCtD
Penciclovir—Rash—Valsartan—type 2 diabetes mellitus	0.000868	0.000868	CcSEcCtD
Penciclovir—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000867	0.000867	CcSEcCtD
Penciclovir—Vomiting—Orlistat—type 2 diabetes mellitus	0.000865	0.000865	CcSEcCtD
Penciclovir—Headache—Valsartan—type 2 diabetes mellitus	0.000862	0.000862	CcSEcCtD
Penciclovir—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000858	0.000858	CcSEcCtD
Penciclovir—Rash—Orlistat—type 2 diabetes mellitus	0.000858	0.000858	CcSEcCtD
Penciclovir—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000857	0.000857	CcSEcCtD
Penciclovir—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000857	0.000857	CcSEcCtD
Penciclovir—Headache—Orlistat—type 2 diabetes mellitus	0.000852	0.000852	CcSEcCtD
Penciclovir—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000849	0.000849	CcSEcCtD
Penciclovir—Somnolence—Ramipril—type 2 diabetes mellitus	0.000849	0.000849	CcSEcCtD
Penciclovir—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000837	0.000837	CcSEcCtD
Penciclovir—Dizziness—Metformin—type 2 diabetes mellitus	0.000829	0.000829	CcSEcCtD
Penciclovir—Fatigue—Ramipril—type 2 diabetes mellitus	0.000823	0.000823	CcSEcCtD
Penciclovir—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.00082	0.00082	CcSEcCtD
Penciclovir—Nausea—Valsartan—type 2 diabetes mellitus	0.000818	0.000818	CcSEcCtD
Penciclovir—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000809	0.000809	CcSEcCtD
Penciclovir—Nausea—Orlistat—type 2 diabetes mellitus	0.000808	0.000808	CcSEcCtD
Penciclovir—Asthenia—Losartan—type 2 diabetes mellitus	0.000799	0.000799	CcSEcCtD
Penciclovir—Vomiting—Metformin—type 2 diabetes mellitus	0.000797	0.000797	CcSEcCtD
Penciclovir—Rash—Metformin—type 2 diabetes mellitus	0.00079	0.00079	CcSEcCtD
Penciclovir—Dermatitis—Metformin—type 2 diabetes mellitus	0.00079	0.00079	CcSEcCtD
Penciclovir—Pruritus—Losartan—type 2 diabetes mellitus	0.000788	0.000788	CcSEcCtD
Penciclovir—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000787	0.000787	CcSEcCtD
Penciclovir—Headache—Metformin—type 2 diabetes mellitus	0.000785	0.000785	CcSEcCtD
Penciclovir—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000782	0.000782	CcSEcCtD
Penciclovir—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000781	0.000781	CcSEcCtD
Penciclovir—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000762	0.000762	CcSEcCtD
Penciclovir—Urticaria—Ramipril—type 2 diabetes mellitus	0.000758	0.000758	CcSEcCtD
Penciclovir—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000755	0.000755	CcSEcCtD
Penciclovir—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000752	0.000752	CcSEcCtD
Penciclovir—Rash—Irbesartan—type 2 diabetes mellitus	0.000746	0.000746	CcSEcCtD
Penciclovir—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000745	0.000745	CcSEcCtD
Penciclovir—Nausea—Metformin—type 2 diabetes mellitus	0.000745	0.000745	CcSEcCtD
Penciclovir—Headache—Irbesartan—type 2 diabetes mellitus	0.000741	0.000741	CcSEcCtD
Penciclovir—Dizziness—Losartan—type 2 diabetes mellitus	0.000736	0.000736	CcSEcCtD
Penciclovir—Vomiting—Losartan—type 2 diabetes mellitus	0.000708	0.000708	CcSEcCtD
Penciclovir—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000703	0.000703	CcSEcCtD
Penciclovir—Nausea—Irbesartan—type 2 diabetes mellitus	0.000703	0.000703	CcSEcCtD
Penciclovir—Rash—Losartan—type 2 diabetes mellitus	0.000702	0.000702	CcSEcCtD
Penciclovir—Dermatitis—Losartan—type 2 diabetes mellitus	0.000701	0.000701	CcSEcCtD
Penciclovir—Headache—Losartan—type 2 diabetes mellitus	0.000698	0.000698	CcSEcCtD
Penciclovir—Asthenia—Ramipril—type 2 diabetes mellitus	0.000685	0.000685	CcSEcCtD
Penciclovir—Pruritus—Ramipril—type 2 diabetes mellitus	0.000675	0.000675	CcSEcCtD
Penciclovir—Nausea—Losartan—type 2 diabetes mellitus	0.000661	0.000661	CcSEcCtD
Penciclovir—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000653	0.000653	CcSEcCtD
Penciclovir—Dizziness—Ramipril—type 2 diabetes mellitus	0.000631	0.000631	CcSEcCtD
Penciclovir—Vomiting—Ramipril—type 2 diabetes mellitus	0.000607	0.000607	CcSEcCtD
Penciclovir—Rash—Ramipril—type 2 diabetes mellitus	0.000602	0.000602	CcSEcCtD
Penciclovir—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000601	0.000601	CcSEcCtD
Penciclovir—Headache—Ramipril—type 2 diabetes mellitus	0.000598	0.000598	CcSEcCtD
Penciclovir—Nausea—Ramipril—type 2 diabetes mellitus	0.000567	0.000567	CcSEcCtD
